Curcumin Inhibits Cigarette Smoke-Induced Inflammation Via Modulating The Ppar Gamma-Nf-Kappa B Signaling Pathway

Qiuping Li,Jing Sun,Nabijan Mohammadtursun,Jinfeng Wu,Jingcheng Dong,Lulu Li
DOI: https://doi.org/10.1039/c9fo02159k
IF: 6.3173
2019-01-01
Food & Function
Abstract:Peroxisome proliferator-activated receptor gamma (PPAR gamma), a ligand-activated nuclear hormone receptor, is considered to be a potential target for the anti-inflammatory treatment of COPD, and its anti-inflammatory efficacy is likely related to the inhibition of transcriptional regulation of nuclear factor (NF)-kappa B. Curcumin, a dietary polyphenol isolated from the rhizome of turmeric, has been found to have therapeutic benefits in chronic obstructive pulmonary disease (COPD) via inhibiting NF-kappa B. However, whether the anti-inflammatory efficacy of curcumin in COPD is associated with PPAR gamma has scarcely been investigated before. The purpose of this study was to validate the relationship between PPAR gamma and NF-kappa B in cigarette smoke (CS)-induced COPD models, and then to investigate whether the therapeutic effect of curcumin on COPD is achieved through modulating the PPAR gamma-NF-kappa B signaling pathway. Our experiments in vitro illustrated that PPAR gamma might be upstream of NF-kappa B in cigarette smoke extract (CSE)-treated Beas-2B cells, and that curcumin could significantly ameliorate CSE-induced cell viability reduction and inflammation though up-regulating PPAR gamma and inhibiting NF-kappa B activation. Importantly, we found that the inhibitory effect on NF-kappa B by curcumin was dependent on PPAR gamma in T0070907-treated or PPAR gamma shRNA-transfected Beas-2B cells, indicating that curcumin inhibited CSE-induced inflammation partially through modulating the PPAR gamma-NF-kappa B pathway. Furthermore, we also observed that the effect of curcumin on PPAR gamma protein expression and NF-kappa B activation in CS-exposed rats was consistent with the results from experiments in vitro, and curcumin effectively attenuated pulmonary function decline and inflammatory responses in CS-exposed rats. In conclusion, all the results revealed that curcumin attenuated CS-induced inflammation both in vivo and in vitro, presumably by modulating the PPAR gamma-NF-kappa B pathway.
What problem does this paper attempt to address?